Dotmatics Joins Pistoia Alliance
News Mar 02, 2015
Dotmatics has joined the Pistoia Alliance, a global, not-for-profit alliance of Life Sciences organisations that work together to lower barriers to innovation in R&D. The Pistoia Alliance was initially formed by major global pharmaceutical companies including Pfizer, GlaxoSmithKline, Novartis and AstraZeneca, and now counts a large group of global companies, start-ups and academic organisations amongst its members.
“Dotmatics is joining our important group of core and participating members that form the heart of the Pistoia Alliance and work together to help define and deliver what we want to achieve as an organisation. I am very happy at the news that Dotmatics has joined us and I am sure it will be a win-win opportunity for all involved,” said Michael Braxenthaler, President of the Pistoia Alliance.
Within the Pistoia Alliance framework, Dotmatics plans to collaborate with the Life Sciences industry as well as other informatics solution vendors to facilitate the creation of standards, debate new ideas with the community, and help lower the barrier to innovation. The modern and agile nature of the Dotmatics Platform provides the perfect grounding for contribution to the Alliance’s objectives. Dotmatics plans to have a strong involvement in all areas of discussion including chemistry and biologicals research, data management and analysis. A topic of permanent conversation amongst Pistoia Alliance members is the implementation of cloud and mobile solutions in the Life Sciences industry. Dotmatics has extensive experience in these areas and a proven track-record of delivering cost-effective collaborative tools for organisations of all sizes.
“We have been interacting with the Pistoia Alliance for some time now but recently made the decision to become official members,” said Dr Stephen Gallagher, CEO at Dotmatics. “We believe that we can make a real contribution towards the resolutions of common issues affecting our customers and we feel that the outcome will facilitate successful collaborative engagement within the industry.”
The Dotmatics Platform is a comprehensive and mature environment that underpins all of the informatics solutions provided by Dotmatics. It is a true collaborative environment where researchers can share ideas, results and discussions in real time. Browser is the main hub of the system providing query and reporting capabilities. Studies Notebook enables users to record chemistry, biological and general data in a complaint ELN. Vortex is the premium data analysis and visualisation tool and there are various additional modular solutions which cover the entire scientific workflow. The Platform can be deployed in local servers or in the cloud and as a mobile system by design, it enables users to work collaboratively from diverse settings.
ExPecto Patronum! Magical Machine Learning Tool Summons DNA Dark Matter DataNews
A new machine learning framework, dubbed ExPecto, can predict the effects of mutations in the so-called “dark matter” regions of the human genome. ExPecto pinpoints how mutations can disrupt the way genes turn on and off throughout your body.
Machine Learning Helps Predict Schizophrenia Treatment OutcomesNews
New research that used a machine-learning algorithm to investigate MRI images of schizophrenia patients has successfully identified response to antipsychotic treatment in 4 out of 5 patients.READ MORE
Big Data Analysis Identifies New Cancer Risk GenesNews
Researchers at the Centre for Genomic Regulation (CRG) in Barcelona have developed a new method to systematically identify genes contributing to heritable cancer risk. Their work, which is published in Nature Communications, is a success story for data sharing and openness in science. A small team of three researchers identified new cancer genes only using publicly available data.READ MORE